Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

808
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
808
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

681
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
681
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

679
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
679
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

472
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
472
Actuarial Approach01:20

Actuarial Approach

345
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obtaining clinical term embeddings from SNOMED CT ontology.

Journal of biomedical informatics·2023
Same author

The deceptive coloboma.

Indian journal of ophthalmology·2023
Same author

Identification and analysis of misclassified work-zone crashes using text mining techniques.

Accident; analysis and prevention·2021
Same author

Clinical Term Normalization Using Learned Edit Patterns and Subconcept Matching: System Development and Evaluation.

JMIR medical informatics·2021
Same author

Automatic full conversion of clinical terms into SNOMED CT concepts.

Journal of biomedical informatics·2020
Same author

A continual prediction model for inpatient acute kidney injury.

Computers in biology and medicine·2020

Related Experiment Video

Updated: Mar 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Stage-specific predictive models for breast cancer survivability.

Rohit J Kate1, Ramya Nadig2

  • 1Department of Health Informatics and Administration, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.

International Journal of Medical Informatics
|December 7, 2016
PubMed
Summary

Machine learning models for breast cancer survivability perform best when trained and evaluated for each cancer stage separately. Combining stages in models leads to misleadingly overestimated performance and poorer predictions.

Keywords:
Breast cancerMachine learningSEER datasetSurvivability prediction

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

979
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.2K

Related Experiment Videos

Last Updated: Mar 10, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

979
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

7.2K

Area of Science:

  • Oncology
  • Biostatistics
  • Machine Learning

Background:

  • Breast cancer survivability varies significantly across different disease stages.
  • Previous machine learning models for breast cancer survivability did not account for stage-specific variations, potentially limiting their accuracy.

Purpose of the Study:

  • To determine if machine learning model performance differs when trained and evaluated on individual breast cancer stages versus combined stages.
  • To investigate stage-specific feature importance in breast cancer survivability prediction.

Main Methods:

  • Developed and compared machine learning models for breast cancer survivability prediction using three distinct algorithms.
  • Models were trained and evaluated both separately for each stage and jointly across all stages.
  • Evaluated model performance across individual stages and aggregated performance metrics.

Main Results:

  • Models trained and evaluated for specific breast cancer stages outperformed models trained on all stages combined.
  • Including data from other stages during training negatively impacted model performance for a given stage.
  • Key predictive features for survivability varied significantly between different breast cancer stages.
  • Aggregated performance evaluation across all stages was misleading and overestimated model accuracy.

Conclusions:

  • Stage-specific training and evaluation are crucial for accurate breast cancer survivability prediction using machine learning.
  • Jointly trained and evaluated models provide an oversimplified and inaccurate view of predictive performance.
  • Understanding stage-specific predictive features can lead to more tailored and effective survivability models.